Abstract
Objective Clustering methods are often applied to electronic medical records (EMR) for various objectives, including the discovery of previously unrecognized disease subtypes. The abundance and redundancy of information in EMR data raises the need to rank the features by their relevance to clustering.
Methods Here we propose FRIGATE, an ensemble feature ranking algorithm for clustering. FRIGATE ranks the features by solving multiple clustering problems on subgroups of features, using game-theoretic principles to rank and weigh features. In every such problem, a Shapley-like framework is utilized to rank a selected set of features. In another version of the algorithm, multiplicative weights are employed to reduce the randomness in feature set selection. The code for the algorithms is available in: https://github.com/Shamir-Lab/FRIGATE.
Results On simulated data and on eleven real genomics and EMR datasets, FRIGATE outperforms extant ensemble ranking algorithms, in solution quality and in speed.
Conclusion Frigate can improve disease understanding by enabling better subtype discovery from EMR data.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported in part by a grant from the Tel Aviv University Center for AI and Data Science (TAD). ES was supported in part by a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel-Aviv University.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The main changes are adding supplementary material and updating table 3.
Data Availability
All real data used in this paper are from publicly available sources. See Table 2 for details.
